Sierra Oncology commits to sharing clinical study data with qualified researchers to enable enhancement of public health.
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib / Mesa, R., Verstovsek, S., Platzbecker, U., Gupta, V., Lavie, D., Giraldo, P., Recher, C., Kiladjian, J., Oh, S.T., Gerds, A.T., Devos, T., Passamonti, F., Vannucchi, A.M., Egyed, M., Lech-Maranda, E., Pluta, A., Nilsson, L., Shimoda, K., McLornan, D., Kawashima, J., et al.. - In: HAEMATOLOGICA. - ISSN 1592-8721. - ELETTRONICO. - (2023), pp. 0-0. [10.3324/haematol.2023.283106]
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib
Vannucchi, Alessandro M;Huang, Mei;
2023
Abstract
Sierra Oncology commits to sharing clinical study data with qualified researchers to enable enhancement of public health.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Clinical outcomes of patients with myelofibrosis.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
2.63 MB
Formato
Adobe PDF
|
2.63 MB | Adobe PDF | Richiedi una copia |
|
11105-Article Text-81269-2-10-20240129.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
5.26 MB
Formato
Adobe PDF
|
5.26 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
